Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis
JGH Open · 2026-07 · 10 (7)
DOI: 10.1002/jgh3.70448 ↗Kurz gefasst
Fachartikel in der Zeitschrift JGH Open, online erschienen am 20.07.2026. Verfasst von Akihisa Adachi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Despite the recommendation of steroid therapy for type 1 autoimmune pancreatitis (AIP), the value of steroid pulse therapy remains unclear. This study aimed to assess the efficacy and safety of steroid pulse therapy in patients with AIP. Methods and Results Of 121 patients with type 1 AIP who were identified, 116 with adequate follow‐up data were included in the analysis. Patients were classified into four groups according to the initial treatment modality—pulse therapy alone (Pulse alone group), pulse therapy followed by oral steroid therapy (Pulse + PSL group), conventional oral steroid therapy (PSL group), and observation without treatment (Observation group)—and short‐ and long‐term clinical response, relapse rates, and steroid‐associated adverse events were compared across these groups. The numbers of patients in the Pulse alone, Pulse + PSL, PSL, and Observation groups were 12, 13, 68, and 23, respectively. After 2 weeks of steroid initiation, steroid pulse groups (Pulse alone and Pulse + PSL group) showed a significantly greater reduction in serum IgG4 levels than the PSL group ( p = 0.048). Pulse + PSL was associated with a significantly lower relapse rate than PSL (log‐rank test p = 0.02; multivariate Cox regression p = 0.048), with no differences in adverse events. Rates of relapse and adverse events did not differ significantly between the Pulse alone and Observation groups.
Conclusions
Steroid pulse therapy may serve as a useful therapeutic option when conducting a steroid trial and may help reduce relapse rate in the management of type 1 AIP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan.
- Department of Gastroenterology Nagoya City University Midori Municipal Hospital Nagoya Japan.
ORCID-Profile: Akihisa Adachi, Itaru Naitoh, Michihiro Yoshida, Yasuki Hori, Akihisa Kato, Tadashi Toyohara, Kenji Urakabe
Zitieren
APA
Adachi, A., Naitoh, I., Yoshida, M., Hori, Y., Kato, A., Kachi, K., Toyohara, T., Oda, K., Kito, Y., Urakabe, K., Mori, T., & Kataoka, H. (2026). Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis. JGH Open, 10(7). https://doi.org/10.1002/jgh3.70448
Vancouver
Adachi A, Naitoh I, Yoshida M, Hori Y, Kato A, Kachi K, et al. Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis. JGH Open. 2026;10(7). doi:10.1002/jgh3.70448
BibTeX
@article{Adachi2026,
author = {Adachi, Akihisa and Naitoh, Itaru and Yoshida, Michihiro and Hori, Yasuki and Kato, Akihisa and Kachi, Kenta and Toyohara, Tadashi and Oda, Kayoko and Kito, Yusuke and Urakabe, Kenji and Mori, Toshitaka and Kataoka, Hiromi},
title = {Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis},
journal = {JGH Open},
year = {2026},
volume = {10},
number = {7},
doi = {10.1002/jgh3.70448}
}
EUVIMED